Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Maki, D. Maki, C. Alvarado, M. Ringer (1991)
Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial cathetersThe Lancet, 338
P. Ng, M. Ault, A. Ellrodt, Lawrence Maldonado (1997)
Peripherally inserted central catheters in general medicine.Mayo Clinic proceedings, 72 3
Last Last, Mansi Mansi, Oakley Oakley, Lofts Lofts (1998)
Long term intravenous access devices: superiority of peripherally inserted central cannulae (PICCs) over Hickman Catheters (HCs)Annals of Oncology, 9
Jeffrey Smith, M. Friedell, M. Cheatham, Samuel Martin, Michael Cohen, John Horowitz (1998)
Peripherally inserted central catheters revisited.American journal of surgery, 176 2
L. Mermel (1994)
Prevention of Intravascular CatheterRelated InfectionsAnnals of Internal Medicine, 132
K. Cheong, D. Perry, C. Karapetis, B. Koczwara (2004)
High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumoursInternal Medicine Journal, 34
O’Grady O’Grady, Alexander Alexander, Dellinger Dellinger, Gerberding Gerberding, Heard Heard, Maki Maki, Masur Masur, McCormick McCormick, Mermel Mermel, Pearson Pearson, Raad Raad, Randolph Randolph, Weinstein Weinstein (2002)
Guidelines for the prevention of intravascular catheter‐related infectionsAmerican Journal of Infection Control, 30
M. Tesselaar, J. Ouwerkerk, F. Rosendaal, S. Osanto (2001)
Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients with centrally but not peripherally inserted central venous catheters for administration of chemotherapyEuropean Journal of Cancer, 37
L. Walshe, S. Malak, J. Eagan, K. Sepkowitz (2002)
Complication rates among cancer patients with peripherally inserted central catheters.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 15
N. Soifer, S. Borzak, B. Edlin, R. Weinstein (1998)
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial.Archives of internal medicine, 158 5
J. Cardella, Kay Cardella, Nancy Bacci, Preston Fox, Jay Post (1996)
Cumulative experience with 1,273 peripherally inserted central catheters at a single institution.Journal of vascular and interventional radiology : JVIR, 7 1
C. Klerk, Susanne Smorenburg, H. Büller (2003)
Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.Archives of internal medicine, 163 16
N. O’grady, M. Alexander, E. Dellinger, J. Gerberding, S. Heard, D. Maki, H. Masur, R. Mccormick, L. Mermel, M. Pearson, I. Raad, A. Randolph, R. Weinstein, J. Siegel, R. Chinn, A. Demaria, E. Larson, James Lee, R. Moncada, W. Rutala, W. Scheckler, B. Stover, M. Underwood (2002)
Guidelines for the prevention of intravascular catheter-related infections.Infection control and hospital epidemiology, 23 12
At our institution, a retrospective review of peripherally inserted central catheters (PICCs) in oncology patients had previously demonstrated a complication rate of 40.7%. Since then we have implemented strategies to reduce complications including staff and patient education, insertion technique modification and PICC maintenance utilizing a PICC nurse. The objectives of this study were to evaluate the recent PICC complication rate and to compare it with the previously reported findings. Prospectively collected PICC complication data and medical records from all patients with solid tumours who had PICCs inserted in 2003 were analysed. A historical cohort comparative analysis was performed using our PICC complication rate from 2000 to 2001. Eighty‐eight PICC lines were inserted in 73 patients under radiological guidance. The median PICC dwell time was 44 days (1–524 days). The overall complication rate was 15.9% (14/88) or 2.0 complications per 1000 PICC‐days. Infections developed in 5.7% (5/88) and thrombotic events occurred in 4.5% (4 /88) of PICCs. The mean time to complication was 45 days. The complication rate for 2003 was significantly lower than the rate for 2001 (P = 0.006), especially of infective complications (P = 0.004). Strategies introduced to reduce PICC complications may have been the reason for this improvement.
European Journal of Cancer Care – Wiley
Published: Sep 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.